januvia pancreatic cancer risk

Future of Type 2 Diabetes Drugs Threatened

According to The New York Times, an animal study requested by Merck for its type 2 diabetes drug, Januvia, revealed worrisome changes in the pancreases of rats, leading to follow-up studies which now threaten the future of the lucrative diabetes drug, as well as all other drugs in its class.

Robinson Calcagnie, Inc. is currently investigating claims against SCE relating to the Eaton Fire to assist victims. Click Here for More Information.